We are live on ! Find out more
GIM

Granahan Investment Management Portfolio holdings

AUM $2.07B
1-Year Est. Return 56.45%
This Fund
S&P 500
This Quarter Est. Return
+16.63%
1 Year Est. Return
+56.45%
3 Year Est. Return
+154.74%
5 Year Est. Return
+144.99%
10 Year Est. Return
+2,452.87%
AUM
$3.05B
AUM Growth
+$310M
Cap. Flow
-$66.5M
Cap. Flow %
-2.18%
Top 10 Hldgs %
16.72%
Holding
249
New
43
Increased
103
Reduced
77
Closed
16

Sector Composition

Rank Sector Weight
1 Technology 35.35%
2 Healthcare 23.41%
3 Industrials 9.47%
4 Financials 9.2%
5 Consumer Discretionary 6.26%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SPSC icon
1
SPS Commerce
SPSC
$2.51B
$56.6M 1.85%
1,541,078
-258,320
-14% -$8.49M
ULTI
2
DELISTED
Ultimate Software Group Inc
ULTI
$56M 1.83%
274,103
+1,170
+0.4% +$247K
TWOU
3
DELISTED
2U Inc
TWOU
$55.1M 1.8%
47,964
-7,977
-14% -$8.33M
GIMO
4
DELISTED
Gigamon Inc.
GIMO
$52.5M 1.72%
958,573
-208,062
-18% -$9.45M
CSGP icon
5
CoStar Group
CSGP
$12.4B
$51.8M 1.7%
2,391,230
-194,000
-8% -$4.13M
TREE icon
6
LendingTree
TREE
$572M
$50.2M 1.64%
517,815
-203,282
-28% -$20.2M
WIX icon
7
WIX.com
WIX
$2.45B
$48.6M 1.59%
1,118,133
+17,790
+2% +$678K
ZLTQ
8
DELISTED
ZELTIQ Aesthetics, Inc.
ZLTQ
$48.5M 1.59%
1,235,543
+74,380
+6% +$2.66M
AMG icon
9
Affiliated Managers Group
AMG
$9.78B
$46.5M 1.52%
321,200
+50,540
+19% +$7.24M
IMAX icon
10
IMAX
IMAX
$2.59B
$44.9M 1.47%
1,550,114
+352,130
+29% +$10.7M
EEFT icon
11
Euronet Worldwide
EEFT
$3.15B
$42.4M 1.39%
517,788
+48,800
+10% +$3.74M
AZTA icon
12
Azenta
AZTA
$1.33B
$41.1M 1.35%
3,021,445
+36,110
+1% +$454K
ABMD
13
DELISTED
Abiomed Inc
ABMD
$38.7M 1.27%
301,083
-20,700
-6% -$2.48M
AXON
14
Axon Enterprise
AXON
$44.1B
$35.5M 1.16%
1,241,651
-49,085
-4% -$1.36M
CPHD
15
DELISTED
Cepheid Inc
CPHD
$35.4M 1.16%
671,400
-327,100
-33% -$13M
EXAS
16
DELISTED
Exact Sciences
EXAS
$35.3M 1.16%
1,901,550
+811,710
+74% +$14.3M
NKTR icon
17
Nektar Therapeutics
NKTR
$2.39B
$34.2M 1.12%
132,875
+853
+0.6% +$220K
EVH icon
18
Evolent Health
EVH
$421M
$33.2M 1.09%
1,348,784
+431,323
+47% +$10.1M
GWR
19
DELISTED
Genesee & Wyoming Inc.
GWR
$32.6M 1.07%
473,173
+198,100
+72% +$13M
LGND icon
20
Ligand Pharmaceuticals
LGND
$5.94B
$31.2M 1.02%
489,595
-31,098
-6% -$2.28M
KAMN
21
DELISTED
Kaman Corp
KAMN
$29.6M 0.97%
674,018
+6,370
+1% +$279K
XLRN
22
DELISTED
Acceleron Pharma
XLRN
$29.6M 0.97%
817,149
+57,530
+8% +$1.91M
RBC icon
23
RBC Bearings
RBC
$18.2B
$29.3M 0.96%
383,243
-69,270
-15% -$5.29M
AIN icon
24
Albany International
AIN
$2.16B
$29.3M 0.96%
691,160
+6,660
+1% +$280K
BIO icon
25
Bio-Rad Laboratories Class A
BIO
$8.86B
$28.7M 0.94%
175,234
-18,400
-10% -$2.79M

Similar funds

Granahan Investment Management's Q3 2016 Portfolio in Review

As of Q3 2016, Granahan Investment Management held 249 positions worth $3.05B, up 11% from $2.74B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Granahan Investment Management's Q3 2016 filing shows 43 new, 103 increased, 77 reduced and 16 closed positions. Its largest new stake was Ellie Mae Inc: 235,070 shares worth $24.8M. The largest sale was LendingTree, an estimated $20.2M.

By sector, the portfolio is most concentrated in Technology at 35% of assets, up from 34% a quarter earlier, followed by Healthcare and Industrials.

  • Granahan Investment Management's largest Q3 2016 buy was Ellie Mae Inc: 235,070 shares worth $24.8M.
  • Granahan Investment Management added most to Pacira BioSciences in Q3 2016, an estimated $18.1M increase.
  • Granahan Investment Management's biggest Q3 2016 reduction was LendingTree, cutting an estimated $20.2M.
  • Granahan Investment Management fully exited Fleetmatics Group PLC in Q3 2016, selling an estimated $17.1M.
  • Granahan Investment Management's ten largest holdings make up 17% of its $3.05B portfolio in Q3 2016.
  • Granahan Investment Management opened 43 new positions and closed 16 in Q3 2016.
  • Granahan Investment Management's portfolio value rose 11% quarter-over-quarter to $3.05B.

Based on Granahan Investment Management's 13F filing for Q3 2016, filed 14 Nov 2016.